Karyopharm Therapeutics – I am paid less than others at the same level | Comparably

Karyopharm Therapeutics – I am paid less than others at the same level

Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
Cette société accepte les commentaires des employés vérifiés
EMPLOYÉ
PARTICIPANTS
90
TOTAL
NOTATIONS
2628
×
Évaluez votre entreprise